What is the current Price Target for the EyeGate Pharmaceuticals, Inc. stock?

The average EyeGate Pharmaceuticals, Inc. target price is $12.24. This is 482.86% higher than the current stock price. The highest price target is 500.00%, the lowest is 477.14%. 3 Analysts have issued a price target EyeGate Pharmaceuticals, Inc. 2026 .

How high will the EyeGate Pharmaceuticals, Inc. stock rise?

No reliable answer can be given as to how high the EyeGate Pharmaceuticals, Inc. stock will rise. The performance of stocks, including the EyeGate Pharmaceuticals, Inc. stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the EyeGate Pharmaceuticals, Inc. stock today?

The performance of EyeGate Pharmaceuticals, Inc. stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the EyeGate Pharmaceuticals, Inc. stock fall?

The decline in EyeGate Pharmaceuticals, Inc. stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

EyeGate Pharmaceuticals, Inc. Forecast, price target & analysts

$2.10

11.11% yesterday

Nasdaq, Dec 03, 10:00 pm CET

ISIN

US30233M1071

Symbol

KPRX

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Pharmaceuticals

Overview Dividends Analysts Charts News Strategies

EyeGate Pharmaceuticals, Inc. Target price 2025 - Analyst rating & recommendation

EyeGate Pharmaceuticals, Inc. Classifications & Recommendation:

Buy

88%

Hold

13%

EyeGate Pharmaceuticals, Inc. Price Target

Target Price	$12.24
Price	$2.10
Potential	482.86% register free of charge
Number of Estimates	3

	3 Analysts have issued a price target EyeGate Pharmaceuticals, Inc. 2026 . The average EyeGate Pharmaceuticals, Inc. target price is $12.24. This is 482.86% register free of charge higher than the current stock price. The highest price target is $12.60 500.00% register free of charge , the lowest is $12.12 477.14% register free of charge .
	A rating was issued by 8 analysts: 7 Analysts recommend EyeGate Pharmaceuticals, Inc. to buy, 1 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the EyeGate Pharmaceuticals, Inc. stock has an average upside potential 2026 of 482.86% register free of charge . Most analysts recommend the EyeGate Pharmaceuticals, Inc. stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '24	2025 Estimates
Earnings Per Share $	0.87	-2.58
	132.34%	396.55%
P/E		negative
EV/Sales		negative

4 Analysts have issued a EyeGate Pharmaceuticals, Inc. forecast for earnings per share. The average EyeGate Pharmaceuticals, Inc. EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$0.87	132.34%
2025	$-2.58 396.55% Unlock
2026	$-2.40 6.98% Unlock
2027	$-2.10 12.50% Unlock

Current	-0.70	128.13%
2025	-0.82 17.14% Unlock
2026	-0.88 7.32% Unlock
2027	-1.00 13.64% Unlock

EyeGate Pharmaceuticals, Inc....

Current EyeGate Pharmaceuticals, Inc. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
HC Wainwright & Co.	Locked ➜ Locked	Locked	Sep 02 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Mar 28 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Nov 12 2024

Analyst Rating	Date
Locked HC Wainwright & Co.: Locked ➜ Locked	Sep 02 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Mar 28 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Nov 12 2024

Discover more stocks with a high price target

Coinbase Global, Inc. 47.34%

BioNTech SE - ADR 46.05%

Deutsche Telekom 42.50%

BYD 40.99%

Novo Nordisk 37.45%

TUI 37.00%

Meta Platforms (Facebook) 35.55%

Adyen 34.62%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now